Weekly Roundup: October 5, 2018


Matthew Harold

Episode Description

This week, Pfizer’s Matthew Harold joins us to discuss the findings of his recent research study that reviewed national policies for rare diseases in the context of key patient needs.
Presenter: Max Rex
Contributor: Matthew Harold, International Developed Markets Public Affairs Lead, Pfizer

Latest episodes

Share this podcast